Kennedy Capital Management LLC Acquires 163,184 Shares of Owens & Minor, Inc. (NYSE:OMI)

Kennedy Capital Management LLC lifted its stake in shares of Owens & Minor, Inc. (NYSE:OMI) by 15.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,216,859 shares of the company’s stock after purchasing an additional 163,184 shares during the period. Kennedy Capital Management LLC’s holdings in Owens & Minor were worth $15,904,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Blue Trust Inc. grew its position in Owens & Minor by 57.4% in the fourth quarter. Blue Trust Inc. now owns 4,387 shares of the company’s stock worth $57,000 after acquiring an additional 1,600 shares in the last quarter. KBC Group NV increased its stake in shares of Owens & Minor by 98.2% during the fourth quarter. KBC Group NV now owns 4,434 shares of the company’s stock valued at $58,000 after purchasing an additional 2,197 shares in the last quarter. Inspire Advisors LLC increased its stake in shares of Owens & Minor by 11.2% during the fourth quarter. Inspire Advisors LLC now owns 15,350 shares of the company’s stock valued at $201,000 after purchasing an additional 1,548 shares in the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of Owens & Minor during the fourth quarter valued at approximately $256,000. Finally, Wealthfront Advisers LLC purchased a new stake in shares of Owens & Minor during the fourth quarter valued at approximately $257,000. 98.04% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Owens & Minor news, major shareholder Coliseum Capital Management, L bought 1,738,511 shares of the business’s stock in a transaction dated Friday, February 28th. The shares were acquired at an average cost of $9.39 per share, with a total value of $16,324,618.29. Following the acquisition, the insider now directly owns 9,469,698 shares of the company’s stock, valued at $88,920,464.22. The trade was a 22.49 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders bought 2,493,412 shares of company stock worth $22,832,558 over the last 90 days. 2.62% of the stock is owned by insiders.

Owens & Minor Trading Down 3.7 %

Shares of OMI stock opened at $7.48 on Thursday. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The firm has a market cap of $577.81 million, a PE ratio of -11.51, a price-to-earnings-growth ratio of 0.20 and a beta of 1.02. The company has a 50-day moving average of $8.53 and a two-hundred day moving average of $11.89. Owens & Minor, Inc. has a 1-year low of $6.07 and a 1-year high of $26.37.

Owens & Minor (NYSE:OMI) last announced its earnings results on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.02. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The company had revenue of $2.70 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same quarter last year, the firm posted $0.69 earnings per share. Owens & Minor’s revenue was up 1.5% compared to the same quarter last year. On average, analysts predict that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor declared that its board has authorized a share repurchase plan on Friday, February 28th that permits the company to repurchase $100.00 million in outstanding shares. This repurchase authorization permits the company to repurchase up to 13.6% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.

Analysts Set New Price Targets

Several brokerages have recently weighed in on OMI. Robert W. Baird lifted their price target on shares of Owens & Minor from $10.00 to $11.00 and gave the stock a “neutral” rating in a research note on Monday, March 3rd. JPMorgan Chase & Co. decreased their price objective on shares of Owens & Minor from $14.00 to $10.00 and set an “underweight” rating on the stock in a research report on Monday, March 10th. Finally, UBS Group decreased their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $13.75.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.